Lv4
450 积分 2020-05-31 加入
Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy
10天前
已完结
Preparation and characterization of a chimeric CD 19 monoclonal antibody
14天前
已完结
CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis
1个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
1个月前
已完结
Progress in the development of cytokine armoured CAR T cells
1个月前
已完结
Phase I/II Study of Adaptive Manufactured Lentiviral Anti-CD20/Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed, Refractory Mantle Cell Lymphoma
4个月前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
4个月前
已完结
Binding mechanisms of therapeutic antibodies to human CD20
4个月前
已完结
TROP-2-targeted antibody-drug conjugate SHR-A1921 for advanced or metastatic solid tumors: A first-in-human phase 1 study
4个月前
已完结
The antibody-drug conjugate sacituzumab govitecan (IMMU-132) represents a potential novel therapeutic strategy in cholangiocarcinoma
4个月前
已完结
皖公网安备34019202002308
